Ottawa will be getting a $40 million refund after it gave Quebec City-based biopharmaceutical company Medicago more than $300 million to develop and manufacture a home-grown COVID-19 vaccine that never made it to market.
The news comes after Conservative, Bloc and NDP MPs on the House of Commons health committee grilled staff from Canada’s procurement department this week over deals the federal government made with Medicago during the pandemic.
The money Medicago received from the federal government included $173 million from Innovation, Science and Economic Development Canada (ISED) in 2020 to help it develop vaccine technology and build its Quebec City manufacturing facility.
In a press release, ISED
